Current Ratio of Atara Biotherapeutics, Inc. from 30 Jun 2015 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Atara Biotherapeutics, Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2015 to 31 Dec 2025.
- Atara Biotherapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 0.87x, a 65% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Atara Biotherapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.87x | +0.34x | +65% | 31 Dec 2025 |
| Q3 2025 | 0.63x | +0.05x | +8.8% | 30 Sep 2025 |
| Q2 2025 | 0.59x | -0.12x | -16% | 30 Jun 2025 |
| Q1 2025 | 0.51x | -0.54x | -52% | 31 Mar 2025 |
| Q4 2024 | 0.53x | -1.17x | -69% | 31 Dec 2024 |
| Q3 2024 | 0.58x | -2.12x | -79% | 30 Sep 2024 |
| Q2 2024 | 0.71x | -2.61x | -79% | 30 Jun 2024 |
| Q1 2024 | 1.05x | -2.99x | -74% | 31 Mar 2024 |
| Q4 2023 | 1.7x | -2.2x | -56% | 31 Dec 2023 |
| Q3 2023 | 2.7x | -1.15x | -30% | 30 Sep 2023 |
| Q2 2023 | 3.32x | -0.62x | -16% | 30 Jun 2023 |
| Q1 2023 | 4.04x | +0.22x | +5.6% | 31 Mar 2023 |
| Q4 2022 | 3.89x | -0.52x | -12% | 31 Dec 2022 |
| Q3 2022 | 3.85x | -1.26x | -25% | 30 Sep 2022 |
| Q2 2022 | 3.94x | -1.95x | -33% | 30 Jun 2022 |
| Q1 2022 | 3.82x | -3.36x | -47% | 31 Mar 2022 |
| Q4 2021 | 4.41x | -3.55x | -45% | 31 Dec 2021 |
| Q3 2021 | 5.11x | -3.71x | -42% | 30 Sep 2021 |
| Q2 2021 | 5.89x | -2.95x | -33% | 30 Jun 2021 |
| Q1 2021 | 7.18x | -0.81x | -10% | 31 Mar 2021 |
| Q4 2020 | 7.96x | -0.63x | -7.4% | 31 Dec 2020 |
| Q3 2020 | 8.83x | +0.06x | +0.67% | 30 Sep 2020 |
| Q2 2020 | 8.84x | -0.88x | -9.1% | 30 Jun 2020 |
| Q1 2020 | 7.99x | -3.49x | -30% | 31 Mar 2020 |
| Q4 2019 | 8.6x | -4.7x | -35% | 31 Dec 2019 |
| Q3 2019 | 8.77x | -4.68x | -35% | 30 Sep 2019 |
| Q2 2019 | 9.72x | -3.45x | -26% | 30 Jun 2019 |
| Q1 2019 | 11.48x | -1.75x | -13% | 31 Mar 2019 |
| Q4 2018 | 13.3x | +0.12x | +0.92% | 31 Dec 2018 |
| Q3 2018 | 13.44x | -6.89x | -34% | 30 Sep 2018 |
| Q2 2018 | 13.17x | -10.3x | -44% | 30 Jun 2018 |
| Q1 2018 | 13.23x | -12.93x | -49% | 31 Mar 2018 |
| Q4 2017 | 13.18x | -14.13x | -52% | 31 Dec 2017 |
| Q3 2017 | 20.33x | -8.48x | -29% | 30 Sep 2017 |
| Q2 2017 | 23.46x | -12.95x | -36% | 30 Jun 2017 |
| Q1 2017 | 26.16x | -4.86x | -16% | 31 Mar 2017 |
| Q4 2016 | 27.31x | -4.46x | -14% | 31 Dec 2016 |
| Q3 2016 | 28.81x | -3.11x | -9.7% | 30 Sep 2016 |
| Q2 2016 | 36.42x | +12.35x | +51% | 30 Jun 2016 |
| Q1 2016 | 31.02x | 31 Mar 2016 | ||
| Q4 2015 | 31.78x | 31 Dec 2015 | ||
| Q3 2015 | 31.92x | 30 Sep 2015 | ||
| Q2 2015 | 24.06x | 30 Jun 2015 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.